Mithra Biotechnology Inc.
@mithracro.com
Mithra Biotechnology Inc. is the first Contract Research Organization (CRO) in Taiwan since 1988. We offer integrated and multi-dimensional CRO services, including bioanalytical services for chemical drugs and biologics, full characterization plans for biologics, bioavailability/bioequivalence (BA/BE) studies, and phase I to IV clinical trials to facilitate pharmaceutical development. Mithra possesses expertise and experience in meeting international standards to serve the fast-growing pharmaceutical industry. We are committed to each project from the very beginning to its completion. It is our goal to exceed clients’ expectations and help achieve your long-term goals.
Mithra Biotechnology Inc.'s Company Logos


Mithra Biotechnology Inc.'s Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1C3461
Biscay
28, 52, 97
219, 55, 25
71, 46, 0, 62
#6D4832
Shingle Fawn
109, 72, 50
22, 37, 31
0, 34, 54, 57
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
About Mithra Biotechnology Inc.
Mithra Biotechnology Inc., established in 1988, is Taiwan’s pioneering Contract Research Organization (CRO) dedicated to enhancing pharmaceutical and biotech research and development. With an unwavering commitment to high-quality science and stringent regulatory standards, Mithra supports global clients in accelerating drug development processes. Their extensive service offerings include small and large molecule drug analysis, GLP bioanalysis, immunogenicity assessment, GMP drug analysis, and clinical trial execution.
Mithra's professional team leverages advanced analytical platforms and international regulatory experience to provide reliable clinical and biological analytical solutions. Their vision focuses on quality and scientific excellence, striving to become the trusted partner in drug development at every stage. As an organization grounded in transparency and teamwork, Mithra deeply understands client needs, ensuring that all solutions are purpose-driven and regulatory-compliant. Continuous improvements in international quality standards highlight Mithra's dedication to maintaining excellence in the evolving landscape of biopharmaceutical research.
